Impact of Renin Angiotensin System Blockade on Renal Function in Health and Disease: An End or a Beginning?

Seminars in Nephrology

Volumn 24, Issue 2, 2004, Pages 141-146

  Abdi, Reza ^a   Brenner, Barry M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CREATININE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; IRBESARTAN; LOSARTAN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; RAMIPRIL; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIHYPERTENSIVE THERAPY; BODY WEIGHT; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIALYSIS; DIET RESTRICTION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NEPHRON; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; SMOKING CESSATION; THROMBOSIS; WEIGHT REDUCTION;

EID: 1642284251     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2003.11.004     Document Type: Article

References (47)

1. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F93, 1981
2. Sugimoto H, Shikata K, Matsuda M, et al: Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41:1426-1434, 1998
3. Mattar AL, Fujihara CK, Ribeiro MO, de Nucci G, Zatz R: Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes. Nephron 74:136-143, 1996
4. Danielson LA, Conrad KP: Prostaglandins maintain renal vasodilation and hyperfiltration during chronic nitric oxide synthase blockade in conscious pregnant rats. Circ Res 79:1161-1166, 1996
5. Anderson S, Brenner BM: Pathogenesis of diabetic glomerulopathy: hemodynamic considerations. Diabetes Metab Rev 4:163-177, 1988
6. Uriu K, Kaizu K, Qie YL, Kai K, Eto S: Effect of acute thromboxane A2 inhibition on the renal hemodynamics in a spontaneously non-insulin-dependent diabetic rat, Otsuka Long-Evans Tokushima Fatty rat. J Diabetes Complications 13:182-186, 1999
7. Rennke HG: Glomerular adaptations to renal injury or ablation. Role of capillary hypertension in the pathogenesis of progressive glomerulosclerosis. Blood Purif 6:230-239, 1988
8. Nagata M, Scharer K, Kriz W: Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture. Kidney Int 42:136-147, 1992
9. Nagata M, Kriz W: Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42:148-160, 1992
10. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 22:112-126, 1982
11. Lee LK, Meyer TW, Pollock AS, Lovett DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 96:953-964, 1995
12. Johnson RJ, Alpers CE, Yoshimura A, et al: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
13. Taal MW, Zandi-Nejad K, Weening B, et al: Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 58:1664-1676, 2000
14. Floege J, Bums MW, Alpers CE, et al: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309, 1992
15. Ziai F, Nagano H, Kusaka M, et al: Renal allograft protection with losartan in Fisher-Lewis rats: Hemodynamics, macrophages, and cytokines. Kidney Int 57:2618-2625, 2000
16. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 4:119-128, 1993
17. Miyatake N, Shikata K, Sugimoto H, et al: Intercellular adhesion molecule I mediates mononuclear cell infiltration into rat glomeruli after renal ablation. Nephron 79:91-98, 1998
18. Ruiz-Ortega M, Ruperez M, Lorenzo O, et al: Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 82:12-22, 2002
19. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161:430-439, 1998
20. Han Y, Runge MS, Brasier AR: Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84:695-703, 1999
21. Cortes P, Riser BL, Zhao X, Narins RG: Glomerular volume expansion and mesangial cell mechanical strain: mediators of glomerular pressure injury. Kidney Int Suppl 45:S11-S16, 1994
22. Cortes P, Zhao X, Riser BL, Narins RG: Role of glomerular mechanical strain in the pathogenesis of diabetic nephropathy. Kidney Int 51:57-68, 1997
23. Harris RC, Akai Y, Yasuda T, Homma T: The role of physical forces in alterations of mesangial cell function. Kidney Int Suppl 45:S17-S21, 1994
24. Riser BL, Cortes P, Heilig C, et al: Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells. Am J Pathol 148:1915-1923, 1996
25. Riser BL, Varani J, Cortes P, Yee J, Dame M, Sharba AK: Cyclic stretching of mesangial cells up-regulates intercellular adhesion molecule-1 and leukocyte adherence: a possible new mechanism for glomerulosclerosis. Am J Pathol 158:11-17, 2001
26. Deen WM, Bohrer MP, Brenner BM: Macromolecule transport across glomerular capillaries: application of pore theory. Kidney Int 16:353-365, 1979
27. Deen WM, Bohrer MP, Robertson CR, Brenner BM: Determinants of the transglomerular passage of macromolecules. Fed Proc 36:2614-2618, 1977
28. Olson JL, de Urdaneta AG, Heptinstall RH: Glomerular hyalinosis and its relation to hyperfiltration. Lab Invest 52:387-398, 1985
29. Oliver JD III, Simons JL, Troy JL, Provoost AP, Brenner BM, Deen WM: Proteinuria and impaired glomerular permselectivity in uninephrectomized fawn-hooded rats. Am J Physiol 267:F917-F925, 1994
30. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
31. Zatz R, Anderson S, Meyer TW, Dunn BR, Rennke HG, Brenner BM: Lowering of arterial blood pressure limits glomerular sclerosis in rats with renal ablation and in experimental diabetes. Kidney Int Suppl 20:S123-S129, 1987
32. Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE: Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials. Am J Kidney Dis 35:695-707, 2000
33. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
34. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med 156:286-289, 1996
35. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118:129-138, 1993
36. Lewis EJ, Hunsicker LG, Clarke WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
37. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
38. Maschio G, Alberti D, Janin G, et al: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939-945, 1996
39. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G: Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril efficacy in nephropathy. Lancet 352:1252-1256, 1998
40. Ruggenenti P, Perna A, Gherardi G, et al: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrofic proteinuria. Lancet 354:359-364, 1999
41. Paul LC: Chronic allograft nephropathy: An update. Kidney Int 56:783-793, 1999
42. Abdi R, Slakey D, Kittur D, Burdick J, Racusen L: Baseline glomerular size as a predictor of function in human renal transplantation. Transplantation 66:329-333, 1998
43. Azuma H, Nadeau K, Mackenzie HS, Brenner BM, Tilney NL: Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 63:519-528, 1997
44. Nadasdy T, Abdi R, Pitha J, Slakey D, Racusen L: Diffuse glomerular basement membrane lamellation in renal allografts from pediatric donors to adult recipients. Am J Surg Pathol 23:437-442, 1999
45. Terasaki PI, Koyama H, Cecka JM, Gjertson DW: The hyperfiltration hypothesis in human renal transplantation. Transplantation 57:1450-1454, 1994
46. Abdi R, Tran TB, Zee R, Brenner BM, Milford EL: Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation 72:726-729, 2001
47. Lin J, Valeri AM, Markowitz GS, D'Agati VD, Cohen DJ, Radhakrishnan J: Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation 73:783-788, 2002